Chrono Therapeutics

At Chrono Therapeutics, we believe effective care of the most hard-to-treat conditions requires approaches beyond simply taking medicine. We are transforming how medicine is delivered and how people achieve their health goals through the convergence of optimized drug delivery, embedded sensor technology to monitor compliance, and connected and personalized behavioral support. Our First Product. Smoking is highly addictive and remains one of the world’s great killers. The World Health Organization estimates that the global death toll is 5 million per year and this is expected to rise to 7 million by 2020. Chrono's first application is in smoking cessation, enabling smokers to overcome the world's deadliest addiction.
Company Growth (employees)
Type
Private
HQ
Waltham, US
Founded
2004
Size (employees)
45 (est)-4%
Chrono Therapeutics was founded in 2004 and is headquartered in Waltham, US

Key People/Management at Chrono Therapeutics

Guy DiPierro

Guy DiPierro

President & COO

Chrono Therapeutics Office Locations

Chrono Therapeutics has an office in Waltham
Waltham, US (HQ)
1377 Main Street

Chrono Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2004

Total Funding

$82.4 m

Latest funding size

$47.6 m

Time since last funding

about 1 year

Investors

Chrono Therapeutics's latest funding round in September 2016 was reported to be $47.6 m. In total, Chrono Therapeutics has raised $82.4 m

Traffic Overview of Chrono Therapeutics

Chrono Therapeutics Online and Social Media Presence

Chrono Therapeutics Company Life and Culture

You may also be interested in